We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016

By LabMedica International staff writers
Posted on 04 Aug 2016
Print article
Image: The EXCM – a compact Cartesian handling system for clinical automation (Image courtesy of Festo).
Image: The EXCM – a compact Cartesian handling system for clinical automation (Image courtesy of Festo).
In active demonstrations and static displays, several automated solutions for diagnostics laboratories and manufacturers are being presented by Festo (Hauppauge, NY, USA, and Esslingen am Neckar, Germany) at the 2016 AACC Annual Meeting & Clinical Lab Expo (July 31 - August 4; Philadelphia, PA, USA).

Equipment manufacturers partnering with Festo typically bring products to market faster. As a case in point, Rheonix, Inc. representatives will be in the Festo booth discussing the impact of Festo automation and productivity programs on the development of the company’s EncompassMDx system – a one-stop solution for molecular diagnostic assays. The EncompassMDx automates sample preparation designed to isolate DNA and RNA from a variety of samples. Its detection capabilities combine the capacity of a microarray with the speed and resolution of qPCR in one unit.

In collaboration with New York University College of Dentistry (NYUCD), Rheonix has received funding to develop a rapid diagnostic capability for the Zika virus. The grant will allow the Rheonix/NYUCD team to pursue development of a fully automated screening and self-confirming assay that will simultaneously detect and confirm the presence of Zika virus in a single small sample of saliva or blood. The proposed approach builds upon previous success in which the Rheonix/NYUCD team developed a dual assay for simultaneous detection of HIV antibodies and viral RNA in a single specimen.

One of a number of Festo systems on display is EXCM – a handling system for clinical automation as a compact benchtop Cartesian robot. An active demonstration features the Mini-H gantry with a Z telescope slide axis for microfluidic dosing. Another demonstration simulates the transfer of whole blood from the specimen to an analysis chip within a small footprint device. In this demo, a gripper removes a vial from a tray and transfers it to an integrated rotary gripping unit. The system’s camera reads a barcode and approves eligibility for testing. This demo features the Festo CPX control system, which reduces the complexity of control and motion integration.

Festo also highlights the Single Axis Variable Pitch Module (SVPM) with up to 8 pipettes – it can aspirate or dispense from a 96 well plate, then expand to a different pitch to aspirate or dispense into a large variety of fluid containers such as tubes, chips, or vials.

The AquaJellies from the Festo Bionic Learning Network are artificial, autonomous jellyfish with electric drives and intelligent, adaptive mechanical systems. AACC attendees will see the bionic jellyfish in their new 500 gallon/1,900 liter tank. The movements of the AquaJellies come as close as possible to simulating jellyfish undulating through the world’s oceans. The integrated communication and sensor technology plus the real-time diagnostics enable coordinated, collective behavior among AquaJellies even in a limited space.

Related Links:
Festo


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.